Recurrence and severity of abnormal pregnancy outcome in patients treated by low-molecular-weight heparin: a prospective pilot study

By Conserva Valentina   Muggiasca Marialuisa   Arrigoni Luisa   Mantegazza Valeria   Rossi Edoardo   Ferrazzi Enrico  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 25, Iss. 8, 2012-08 ,pp. : 1467-1473

Informa Healthcare

Access to resources Recommend Favorite

The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancy

By Eldor A.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 104, Iss. 1, 2002-08 ,pp. : 3-13

Elsevier

Access to resources Recommend Favorite

Severe hyperlipidaemia in pregnancy related to the use of low-molecular-weight heparin-enoxaparin sodium (clexane)

By Tomsu M.   Li T. C.   Preston F.   Forrest A. R. W.  

Journal of Obstetrics & Gynaecology, Vol. 18, Iss. 1, 1998-01 ,pp. : 83-84

Informa Healthcare

Access to resources Recommend Favorite

High dose low-molecular-weight heparin (enoxaparin) for the treatment of recurrent thromboembolism in pregnancy

By Lindow S W   Masson E A   Atkin S L  

Journal of Obstetrics & Gynaecology, Vol. 17, Iss. 2, 1997-03 ,pp. : 168-168

Informa Healthcare

Access to resources Recommend Favorite

Osteopenic fractures in pregnancy: Is low molecular weight heparin (LMWH) implicated?

By Byrd L. M.   Shiach C. R.   Hay C. R. M.   Johnston T. A.  

Journal of Obstetrics & Gynaecology, Vol. 28, Iss. 5, 2008-07 ,pp. : 539-542

Informa Healthcare

Access to resources Recommend Favorite